Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
RSS icon

RSNA: Now's the time for IHE, REM and XDS-I profiles

CHICAGOWith the passage of the American Recovery and Reinvestment Act, IHE (Integrating the Healthcare Enterprise) has found its moment in time, said David Mendelson, MD, chief of clinical informatics and director of radiology information systems at Mount Sinai Medical Center in New York City, during a session at the Radiological Society of North America (RSNA) meeting on IHE and integration issues.

GE unveils new MR elastography technology

As part of its Healthymagination venture, GE Healthcare has unveiled its MR-Touch, MR elastography (MRE) technology that will soon be made commercially available.

AJR: Blood test may rule out need for repeat breast MRIs

Optimal scheduling of breast MRI exams can be achieved by a simple blood test searching for Serum progesterone concentrations related to the follicular phase (days three-14) of a normal menstrual cycle in premenopausal women with irregular cycles, said a recent analysis published in the December issue of the American Journal of Roentgenology.

Philips, BrainLAB equip new pediatric neurosurgery suite

The Montreal Childrens Hospital of the McGill University Health Centre in Quebec has opened a new combined MRI/operating room suite for image-guided neurosurgery.

Study: Dynamic bests static MRI in identifying urethral abnormality

Dynamic MRI allows for the detection of pelvic organ prolapse or displacement within the body that may not be visible on conventional static MRI scans, according to a study published in the December issue of the American Journal of Roentgenology.

FDA: GE, Bayer, Covidien MR agents carry highest risk

After years of research regarding gadolinium-based contrast agents used during MRI being linked to the skin disease nephrogenic systemic fibrosis (NSF), the FDA has found the greatest risk in GE Healthcares Omniscan, Bayer HealthCare's Magnevist and Covidiens Optimark.

Study: Health IT fails to reduce healthcare costs

The increased computerization of U.S. hospitals hasn't made them cheaper or more efficient, although it may modestly improve the quality of care for heart attacks, Harvard researchers reported in the Nov. 20 edition of the American Journal of Medicine.

Equity funds to buy Esaote for more than $415M

Intesa Sanpaolo and Ares Life Sciences, private equity funds focused on investing in the biomedical and healthcare sectors, have reached an agreement to acquire ultrasound and MRI technology developer Esaote for EUR280 million ($415.7 million, U.S.).

Displaying 6721 - 6728 of 6920

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup